89bio Inc Stock Investor Sentiment
| ETNB Stock | USD 8.96 0.20 2.28% |
About 54% of 89bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding 89bio Inc suggests that some traders are interested. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
89bio |
89bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.
89bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 16527 shares by Rohan Palekar of 89bio at 18.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 5352 shares by Le-nguyen Quoc of 89bio at 8.46 subject to Rule 16b-3 | 09/09/2024 |
3 | Health Check How Prudently Does 89bio Use Debt | 09/26/2024 |
4 | Disposition of 9671 shares by Mansbach Harry H of 89bio at 11.53 subject to Rule 16b-3 | 09/27/2024 |
5 | Renaissance Technologies LLC Invests 2.24 Million in 89bio, Inc. - MarketBeat | 10/03/2024 |
6 | 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 10/11/2024 |
7 | Acquisition by Le-nguyen Quoc of 8334 shares of 89bio subject to Rule 16b-3 | 10/14/2024 |
8 | 89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis at AASLD The Liver Meeting 2024 | 10/15/2024 |
9 | Disposition of 27955 shares by Le-nguyen Quoc of 89bio at 8.12 subject to Rule 16b-3 | 10/30/2024 |
10 | 89bio Reports Third Quarter 2024 Financial Results and Corporate Updates | 11/07/2024 |
11 | 89bio, Inc. Announces Upsized Pricing of 125.0 Million Public Offering of Common Stock and Pre-Funded Warrants | 11/13/2024 |
12 | 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Li... | 11/15/2024 |
13 | 89Bio Inc. Reports Q3 2024 Financial Results - TipRanks | 11/20/2024 |
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |